In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 8, 2004, Pages 3127-3129

  Braunstein, Amir ^a   Papo, Niv ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN; LEUCYLLYSYLLEUCYLLEUCYLLYSYLLYSYLLEUCYLLEUCYLLYSYLLYSYSLLEUCYLLEUCYLLYSYLLE UCYLLEUCINAMIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIOLYSIS; BIOPHYSICS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENCY; IN VITRO STUDY; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; STEREOISOMERISM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINO ACIDS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CELL MEMBRANE; DRUG RESISTANCE, BACTERIAL; FEMALE; GENTAMICINS; INJECTIONS, INTRAVENOUS; MICE; MICROSCOPY, CONFOCAL; NEUTROPENIA; PEPTIDES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STEREOISOMERISM; TRYPSIN;

EID: 3342965837     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.8.3127-3129.2004     Document Type: Article

References (33)

1. Avrahami, D., Z. Oren, and Y. Shal. 2001. Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides. Biochemistry 40:12591-12603.
2. Bessalle, R., A. Kapitkovsky, A. Gorea, I. Shalit, and M. Fridkin. 1990. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 274:151-155.
3. Boman, H. G. 1995. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:61-92.
4. Chen, J., T. J. Falla, H. Liu, M. A. Hurst, C. A. Fujii, D. A. Mosca, J. R. Embree, D. J. Loury, P. A. Radel, C. Cheng Chang, L. Gu, and J. C. Fiddes. 2000. Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55:88-98.
5. Cirioni, O., A. Giacometti, R. Ghiselli, F. Mocchegiani, A. Fineo, F. Orlando, M. S. Del Prete, M. Rocchi, V. Saba, and G. Scalise. 2002. Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. Antimicrob. Agents Chemother. 46:101-104.
6. Devine, D. A., and R. E. Hancock. 2002. Cationic peptides: distribution and mechanisms of resistance. Curr. Pharm. Des. 8:703-714.
7. Goldstein, B. P., J. Wei, K. Greenberg, and R. Novick. 1998. Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J. Antimicrob. Chemother. 42:277-278.
8. Gunseren, F., L. Mamikoglu, S. Ozturk, M. Yucesoy, K. Biberoglu, N. Yulug, M. Doganay, B. Sumerkan, S. Kocagoz, S. Unal, S. Cetin, S. Calangu, I. Koksal, H. Leblebicioglu, and M. Gunaydin. 1999. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. J. Antimicrob. Chemother. 43:373-378.
9. Hancock, R. E., and G. Diamond. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402-410.
10. Hancock, R. E., and M. G. Scott. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 97:8856-8861.
11. Ingham, A., M. Ford, R. J. Moore, and M. Tizard. 2003. The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J. Antimicrob. Chemother. 51:1365-1371.
12. Joly-Guillou, M. L., M. Wolff, J. J. Pocidalo, F. Walker, and C. Carbon. 1997. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob. Agents Chemother. 41:345-351.
13. Lehrer, R. I., and T. Ganz. 1999. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11:23-27.
14. McPhee, J. B., S. Lewenza, and R. E. Hancock. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217.
15. Navon-Venezia, S., R. Feder, L. Gaidukov, Y. Carmeli, and A. Mor. 2002. Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob. Agents Chemother. 46:689-694.
16. Nicolas, P., and A. Mor. 1995. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49:277-304.
17. Oren, Z., J. Hong, and Y. Shai. 1997. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 272:14643-14649.
18. Pacor, S., A. Giangaspero, M. Bacac, G. Sava, and A. Tossi. 2002. Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. J. Antimicrob. Chemother. 50:339-348.
19. Pag, U., M. Oedenkoven, N. Papo, Z. Oren, Y. Shai, and H. G. Sahl. 2004. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. J. Antimicrob. Chemother. 53:230-239.
20. Papo, N., Z. Oren, U. Pag, H. G. Sahl, and Y. Shai. 2002. The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J. Biol. Chem. 277:33913-33921.
21. Pouny, Y., D. Rapaport, A. Mor, P. Nicolas, and Y. Shai. 1992. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 31:12416-12423.
22. Russell, P. E., R. J. Milling, and K. Wright. 1995. The need for new antibiotics: possible ways forward, p. 67-85. In P. A. Hunter, G. K. Darby, and N. J. Russell (ed.), Fifty years of antimicrobials: past perspectives and future trends. Cambridge University Press, Cambridge, United Kingdom.
23. Scott, M. G., and R. E. Hancock. 2000. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20:407-431.
24. Scott, M. G., H. Yan, and R. E. Hancock. 1999. Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect. Immun. 67:2005-2009.
25. Shai, Y. 2002. From innate immunity to de-novo designed antimicrobial peptides. Curr. Pharm. Des. 8:715-725.
26. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
27. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248.
28. Steinberg, D. A., M. A. Hurst, C. A. Fujii, A. H. Kung, J. F. Ho, F. C. Cheng, D. J. Loury, and J. C. Fiddes. 1997. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41:1738-1742.
29. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
30. Wade, D., A. Boman, B. Wahlin, C. M. Drain, D. Andreu, H. G. Boman, and R. B. Merrifield. 1990. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. USA 87:4761-4765.
31. Weidenmaier, C., S. A. Kristian, and A. Peschel. 2003. Bacterial resistance to antimicrobial host defenses-an emerging target for novel antiinfective strategies? Curr. Drug Targets 4:643-649.
32. Wu, M., E. Maier, R. Benz, and R. E. Hancock. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38:7235-7242.
33. Zasloff, M. 2002. Antimicrobial peptides in health and disease. N. Engl. J. Med. 347:1199-1200.